schizandrin b has been researched along with tanshinone ii a in 1 studies
Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) |
---|---|---|---|---|---|
9 | 0 | 7 | 61 | 0 | 41 |
Protein | Taxonomy | schizandrin b (IC50) | tanshinone ii a (IC50) |
---|---|---|---|
Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 4.82 | |
Spike glycoprotein | Betacoronavirus England 1 | 0.8 | |
Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.8 | |
caspase-9 isoform alpha precursor | Homo sapiens (human) | 11.2 | |
caspase-3 isoform a preproprotein | Homo sapiens (human) | 11.2 | |
Telomerase reverse transcriptase | Homo sapiens (human) | 2.75 | |
Transmembrane protease serine 2 | Homo sapiens (human) | 0.8 | |
Procathepsin L | Homo sapiens (human) | 0.8 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.14 | |
Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.2 | |
Replicase polyprotein 1ab | Human coronavirus 229E | 0.8 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.1855 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.69 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 2.14 | |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 2.59 | |
Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 6.855 | |
Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 6.855 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for schizandrin b and tanshinone ii a
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |